Angel F Álvarez-Prado

6PUBLICATIONS
29CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursInnate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2021
An integrated pipeline for comprehensive analysis of immune cells in human brain tumor clinical samples.

Roeltje R Maas, Klara Soukup, Florian Klemm

|Dec 28, 2020
Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma.

Pilar Delgado, Ángel F Álvarez-Prado, Ester Marina-Zárate

|Jun 25, 2020
Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.

Carlos Baliñas-Gavira, María I Rodríguez, Alvaro Andrades

|Dec 06, 2019
Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.

Guillermo Rodríguez-Hernández, Friederike V Opitz, Pilar Delgado

|Jan 28, 2018
A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets.

Ángel F Álvarez-Prado, Pablo Pérez-Durán, Arantxa Pérez-García

|Feb 12, 2017
miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.

Nahikari Bartolomé-Izquierdo, Virginia G de Yébenes, Angel F Álvarez-Prado

Pageof 1